News

Fiducial markers sales are anticipated to surpass 100 Mn by 2019, registering an upswing from 93.9 Mn in 2018, according to a Fact.MR study. As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise. The escalating demand for fiducial markers can be accredited to,

• Growing adoption of radiotherapy devices by oncologists
• Surging demand for IGRT and SBRT procedures
• Versatility of fiducial markers in effective diagnosis
• Increasing rates of cancer across the globe

As per the Fact.MR study, the adoption of fiducial markers for prostate cancer have been witnessing a persistent increase, driven by their ability in terms of seamless target precision. Thus, rising adoption of fiducial markers as an effective tool for use in case of radiation treatment is fostering its popularity.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

According to a latest research study by Fact.MR the global lewy body dementia treatment market is projected to surpass US$ 3,650 Mn in 2019, up from nearly 3,500 Mn in 2018. Broader factors concerning the healthcare industry, especially renewed focus on managing geriatric and mental health issues, are likely to impact growth of lewy body dementia treatment market.

Cholinesterase inhibitors will remain the topselling drugs for treating lewy body dementia, accounting for nearly 60% share in 2018. The demand for cholinesterase inhibitors will be followed by antipsychotic drugs owing to their minimal side effects in management of lewy body dementia.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1154

The study opines that macro-economic factors, including growing geriatric population, increasing per capita healthcare expenditure, and paradigm shift towards a value-based healthcare model will drive market growth. Increasing healthcare spending has the potential to directly impact the need for lewy body dementia diagnostics and treatment solutions, which, in turn, will create growth opportunities for stakeholders in the market.

According to the latest market report published by Fact MR, titled ‘Global Wound Irrigation Solution Market: Forecast, Trend Analysis & Competition Tracking - Global Review: 2018- 2028’, the global wound irrigation solution market is expected to expand at a significant CAGR during the forecast period 2018–2028.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1166

The wound irrigation solution market is segmented based on product type, end user and region. On the basis of product type, the wound irrigation solution market has been segmented into two segments such as wetting agents and antiseptics. The antiseptics segment of wound irrigation solution market is expected to be the fast-growing segment over the forecast period, registering a significant CAGR in terms of growth, whereas wetting agents segment is expected to maintain dominance in terms of revenue in the wound irrigation solution market. The increasing demand for advanced wound care solution owing to the growing number of chronic wounds worldwide is expected to boost the growth of the wound irrigation solution market over the forecast period.

Deutsche Post Direkt entwickelt Plugin für Magento Shopsystem - Postleitdaten gestalten Bestellungen schnell, komfortabel, fehlerfrei

Fact.MR delivers key insights on the global vestibular testing system market in its upcoming report titled “Vestibular Testing System Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global vestibular testing system market is projected to register a CAGR of 6.8% over the forecast period, owing to various factors, regarding which FMR offers detailed insights and forecasts in this report.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1313

In 2019, the market size of Automatic UV Water Purifiers is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Automatic UV Water Purifiers.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-europe-china-united...

This report studies the global market size of Automatic UV Water Purifiers, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Automatic UV Water Purifiers production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

The contract pharmaceutical fermentation services market is anticipated to continue its steady growth on back of the evolving use of fermentation techniques to develop active pharmaceutical ingredients (API) coupled with active research studies, and progressive regulatory scenario. The global contract pharmaceutical fermentation services market is envisaged to account for over US$ 4 billion by 2026, according to a recent analysis by Fact.MR.

The study opines that fermentation has become an integral part of drug and toll manufacturing, as firms seek to produce core compounds that can be further used in forming final products.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1517

Funding for early stage advanced biotechnology is increasing and companies commercializing fermentation-sourced technologies are either building their own demonstration-scale facility or using existing contract manufacturing organizations (CMOs). Several pharmaceutical companies are increasingly leveraging contract pharmaceutical fermentation services, which as per Fact.MR is likely to contribute over nearly US$ 2,400 million by value by 2026-end.

In 2018, the global Metal Injection Molding (MIM) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Metal Injection Molding (MIM) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metal Injection Molding (MIM) development in United States, Europe and China.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-metal-injection-mol...

The key players covered in this study

Dynacast
GKN PLC
Britt Manufacturing
Dean Group International
Cypress Industries
Sintex
CMG Technologies
Indo-MIM Pvt
Real Technik AG
ATW Companies
Market segment by Type, the product can be split into

Carbonyl Method
High-Pressure Gas Atomization
Ultra-High Pressure Water Atomization
Market segment by Application, split into

Automotive
Mechanical
Consumer Electronics
Other
Market segment by Regions/Countries, this report covers

FORTEC nimmt Embedded Computer mit erweitertem Temperaturbereich für industriellen Einsatz ins Programm

Prof. Decker, Dr. Sprenger und Dr. Mahlberg erhalten erneut das Leading Medicine Guide Siegel

Das Klinikum Mutterhaus ist mit den drei Standorten, Mutterhaus Mitte, Mutterhaus Nord und Mutterhaus Ehrang, das größte Klinikum in Trier und wird als gGmbH medizinisch und kaufmännisch partnerschaftlich geführt. Jährlich werden rund 41.500 Patienten stationär und 86.500 Patienten ambulant behandelt.

Mit den drei Fachärzten Professor Dr. med. Pan Decker, Facharzt für Chirurgie und Chefarzt im Darmzentrum, Dr. med. Christian Sprenger, Facharzt für Chirurgie und Gefäßchirurgie und Chefarzt im Gefäßchirurgie-Klinikum, und Dr. med. Rolf Mahlberg, Facharzt für Innere Medizin, onkologische Intensiv- und Notfallmedizin, Chefarzt der Inneren Medizin und Leiter des Onkologischen Zentrums, ist ein hochspezialisiertes Expertenteam für die Patienten da.